search button
Open Access

Effect of prophylactic TACE on 5‑year survival of patients with hepatocellular carcinoma after hepatectomy

  • Authors:
    • Shasha He
    • Xiaotang Fan
    • Hailin Ma
    • Hali Xiaerfuhazi
    • Aliya Rehato
    • Juan Feng
    • Xiujiang Shi
    • Fangping He

  • View Affiliations

  • Published online on: June 21, 2019     https://doi.org/10.3892/ol.2019.10517
  • Pages: 1824-1830

  • Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to establish a prediction index (PI) model for the 5‑year survival rate of patients with hepatitis B‑related hepatocellular carcinoma (HCC) after radical resection, and to evaluate the effect of prophylactic transcatheter arterial chemoembolization (TACE). A total of 201 patients with hepatitis B‑related HCC who had undergone radical hepatic resection at The First Affiliated Hospital of Xinjiang Medical University (Xinjiang, China) were enrolled, and the clinical, pathological and complete follow‑up data were collected. Univariate and multivariate Cox regression analyses were performed to identify which clinicopathological factors were considered significant risk factors and the PI model was established based on these factors. The receiver operating characteristic curve was generated, and the area under the curve (0.841) and the cut‑off value for PI were calculated. A Kaplan‑Meier plot was used for survival analysis and the log‑rank test was used to determine differences in survival. Cox regression analysis demonstrated that there were seven independent factors that may have affected the 5‑year survival of HCC patients: Neutrophil‑to‑lymphocyte ratio (NLR), maximum size of tumor (MTS), tumor histological grade (HG), positive resection margin (PRM), microvascular invasion (MVI), the amount of tumor (AT), and antivirus therapy (AVT). A PI model on 5‑year survival was established based on these factors, which was PI=0.32 x NLR + 0.39 x HG (high=1, medium=2, low=3) + 0.92 x PRM (yes=1, no=0) + 0.87 x MVI (yes=1, no=0) + 0.73 x AT (single=0, many=1) + 0.53 x MTS (≥5 cm=1, <5 cm=0)‑0.87 x AVT (yes=1, no=0). PI was an independent predictor for survival, with a cut‑off value of 2.75. For low‑risk patients (PI <2.75), there was no significant difference in cumulative survival between TACE and non‑TACE. For high‑risk patients (PI >2.75), the cumulative survival rates showed significant differences among patients who had received ≥3 TACE procedues, patients who had received <3 TACE procedures, and patients who had not undergone TACE. The PI model predicts the 5‑year survival rate of patients with hepatitis B‑related HCC. For high‑risk patients with a PI >2.75, if they had received ≥3 prophylactic TACE procedures, they demonstrated a more favorable outcome. For low‑risk patients (PI <2.75) with 1 or 2 risk factors, TACE is recommended 1‑2 times after surgery. TACE treatment is not required for low‑risk patients without any risk fctors. These results may contribute to the decision‑making process for whether prophylactic intervention is recommended after radical resection of HCC.
View Figures
View References

Related Articles

Journal Cover

August-2019
Volume 18 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.9
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 6.3
  • CiteScore Rank: Q2: #119/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.725
  • SCImago Journal Rank (SJR): 0.639
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
He S, Fan X, Ma H, Xiaerfuhazi H, Rehato A, Feng J, Shi X and He F: Effect of prophylactic TACE on 5‑year survival of patients with hepatocellular carcinoma after hepatectomy. Oncol Lett 18: 1824-1830, 2019
APA
He, S., Fan, X., Ma, H., Xiaerfuhazi, H., Rehato, A., Feng, J. ... He, F. (2019). Effect of prophylactic TACE on 5‑year survival of patients with hepatocellular carcinoma after hepatectomy. Oncology Letters, 18, 1824-1830. https://doi.org/10.3892/ol.2019.10517
MLA
He, S., Fan, X., Ma, H., Xiaerfuhazi, H., Rehato, A., Feng, J., Shi, X., He, F."Effect of prophylactic TACE on 5‑year survival of patients with hepatocellular carcinoma after hepatectomy". Oncology Letters 18.2 (2019): 1824-1830.
Chicago
He, S., Fan, X., Ma, H., Xiaerfuhazi, H., Rehato, A., Feng, J., Shi, X., He, F."Effect of prophylactic TACE on 5‑year survival of patients with hepatocellular carcinoma after hepatectomy". Oncology Letters 18, no. 2 (2019): 1824-1830. https://doi.org/10.3892/ol.2019.10517